NCT00088946 2020-07-31
Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Completed
Clinical Trials
8 trialsNCT01060345 2020-04-09
A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ
University of Chicago
Phase 2 Terminated
NCT00005097 2018-04-05
Green Tea Extract in Treating Patients With Actinic Keratosis
University of California, Irvine
Phase 2 Terminated
NCT01606124 2017-10-27
Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer
Mayo Clinic
Phase 2 Terminated
NCT00676793 2017-09-21
A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression
Louisiana State University Health Sciences Center Shreveport
Phase 2 Completed
NCT00363805 2013-11-28
Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary Disease
University of Arizona
Phase 2 Completed
NCT00676780 2012-08-08
Green Tea Extract and Prostate Cancer
Louisiana State University Health Sciences Center Shreveport
Phase 2 Completed
NCT01340599 2012-03-15
Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing Surgery
Case Comprehensive Cancer Center
Phase 2 Terminated